A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a timely manner for patients with ovarian cancer, emphasizing the need for ...

James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...

Illumina, Inc. ILMN has secured the FDA’s approval for its in vitro diagnostic (IVD) TruSight Oncology (TSO) Comprehensive test and first two companion diagnostic (CDx) indications. The test analyses ...

Michigan-based Priority Health plans a bold step in cancer detection and treatment: It will cover the cost of comprehensive genomic profiling for members diagnosed with aggressive forms of cancer, ...